Viewing Study NCT01220232

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 9:24 PM
Ignite Modification Date: 2026-06-15 @ 4:43 AM
Study NCT ID: NCT01220232
Status: COMPLETED
Last Update Posted: 2011-02-04
First Post: 2010-10-12
Is NOT Gene Therapy: True
Has Adverse Events: False
Brief Title: Estimate The Effect Of Lersivirine On The Pharmacokinetics Of Abacavir/Lamivudine In Healthy Subjects
Sponsor: Pfizer
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Healthy Volunteers View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Lersivirine View
None UK-453 View
None 061 View
None NNRTI View
None Abacavir View
None Lamivudine View
None Combivir View
None Pharmacokinetics View
None Drug Interaction View
None HIV View
None AIDS View